On a recent video episode of The Data Standard Podcast, biostatistician Nisha Mulakken discusses the Lawrence Livermore Microbial Detection Array (LLMDA) system, which has detection capability for all variants of SARS-CoV-2.
Nisha Mulakken is advancing COVID-19 R&D and mentoring the next generation. “The opportunities we are exposed to early in our careers can shape the limits we place on ourselves and our approaches to challenges we encounter throughout our careers,” she says.
The Livermore Metagenomic Analysis Toolkit (LMAT) is a genome sequencing technology that helps accelerate the comparison of genetic fragments with reference genomes and improve the accuracy of the results as compared to previous technologies. It tracks approximately 25 billion short sequences and is currently being evaluated for potential operational use in global biosurveillance and microbial forensics by various federal agencies.